CAPITAL

Industry Trends: New Report Sheds Light on DX Tech Capital Flows

The health care industry has raised $5 billion in venture fund investment in the first half of 2017 and is well on pace to smash the single year record of $7.5 billion set in 2015, according to … [Read more...]

PAMA

Draft 2018 CLFS Reveals Fundamental Flaws in PAMA Reporting Exercise; Time to Take Action

By Lâle White  bio As XIFIN predicted, the PAMA reporting exercise has resulted in significant proposed laboratory fee cuts. In fact, the multi-year decrease for the top 20 laboratory tests … [Read more...]

INDUSTRY BUZZ

Company of the Month: Interpace Diagnostics

Question: What do Parsippany, NJ-based Interpace Diagnostics and butter have in common? Answer: They're both on a roll. July 27: The molecular lab announces that Cigna will cover its ThyGenX … [Read more...]

PRECISION MEDICINE

Medicare Reimbursement: 4 Molecular Assays Score Big Coverage Wins

Molecular labs continue to gain ground with Medicare securing four key approvals via finalization of Local Coverage Determinations (LCDs) issued by principal contractor Palmetto GBA this spring. All … [Read more...]

MARKETING

Inside the Lab Industry: The Surge of Do-It-Yourself Test Kits

Consumerism, patient empowerment and affordability are key drivers in the modern medical industry. One of the key manifestations of this within the clinical laboratories sector is the rapid growth of … [Read more...]

DEALS

Industry Buzz: The Diagnostic Market’s M&A Highlights from 1H 2017

As usual, the Big 3 of Abbott, Quest and LabCorp were the driving force of M&A activity in the diagnostics industry in the first half of 2017. Abbott Continues to Make News Each company … [Read more...]

ORDERING PHYSICIANS

Ordering Physicians: Oncologists Say Genomic Testing Is Overhyped

When it comes to measuring Dx product effectiveness, few things speak louder than the attitudes of ordering physicians. With that in mind, genomic test manufacturers might want to take pause from a … [Read more...]

NEWS

Focus On: Quest-Walmart Deal Latest in Mass Retailing of Lab Tests

Laboratory test products have been appearing on the shelves of mass retail stores with growing frequency. But the newly announced partnership between Walmart and Quest Diagnostics raises eyebrows … [Read more...]

MOLECULAR TESTS

Palmetto Gives Okay to Medicare Coverage of 5 New Molecular Tests

Medicare contractors are slowly coming around on covering unproven molecular assays. The most notable new baby steps come from, Palmetto GBA (Columbia, SC), one of Medicare's most important … [Read more...]

DOJ

Medical Necessity Requirement Bites Anatomic Pathologists

By Robert Mazer  bio The DOJ has announced two separate settlements involving claims for allegedly unnecessary special stains. Medicare permits a pathologist to order special stains when … [Read more...]


(-0000g2)